A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure

NCT06746064 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Fibrosis

Interventions

DRUG: CHF10073 (Part 1 - SAD)
DRUG: Placebo (Part 1 - SAD)
DRUG: CHF10073 (Part 2 - MAD)
DRUG: CHF10073 (Part 3)
DRUG: Placebo (Part 2 - MAD)
DRUG: itraconazole (Part 4)
DRUG: CHF10073 (Part 4)

Sponsor

Chiesi Farmaceutici S.p.A.